The multiple sclerosis monitoring study: Progress to date

The multiple sclerosis monitoring study: Progress to date

Bibliographische Detailangaben
Hauptverfasser:	Cooper, C, Palace, J, Pickin, M, Boggild, M, Nichol, J, Consortium, MS
Format:	Conference item
Veröffentlicht:	2004

Ähnliche Einträge

The Multiple Sclerosis Risk Sharing Scheme Monitoring Study – early results and lessons for the future
von: Pickin, M, et al.
Veröffentlicht: (2009)

The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future.
von: Pickin, M, et al.
Veröffentlicht: (2009)

The UK Multiple Sclerosis database.
von: Palace, J, et al.
Veröffentlicht: (1999)

Modifying disability in progressive multiple sclerosis.
von: Palace, J, et al.
Veröffentlicht: (2014)

Modifying disability in progressive multiple sclerosis
von: Palace, J, et al.
Veröffentlicht: (2014)

EVIDENCE OF SUBCORTICAL ATROPHY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
von: Arun, T, et al.
Veröffentlicht: (2009)

The UK long-term cost-effectiveness study of disease-modifying therapies in multiple sclerosis: lessons from tire first analysis
von: Palace, J, et al.
Veröffentlicht: (2008)

Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex
von: Yates, R, et al.
Veröffentlicht: (2017)

Modelling natural history for the UK multiple sclerosis risk-sharing scheme
von: Palace, J, et al.
Veröffentlicht: (2013)

Making the diagnosis of multiple sclerosis.
von: Palace, J
Veröffentlicht: (2001)

Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator.
von: Boggild, M, et al.
Veröffentlicht: (2009)

Progress in deciphering the genetics of multiple sclerosis.
von: Herrera, B, et al.
Veröffentlicht: (2003)

New and old treatments for multiple sclerosis.
von: Palace, J
Veröffentlicht: (1998)

The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.
von: Kremenchutzky, M, et al.
Veröffentlicht: (1999)

The natural history of multiple sclerosis: a geographically based study 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation
von: Kremenchutzky, M, et al.
Veröffentlicht: (1999)

UK multiple sclerosis risksharing scheme: A new natural history dataset and an improved Markov model
von: Palace, J, et al.
Veröffentlicht: (2014)

Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group.
von: Noseworthy, J, et al.
Veröffentlicht: (1989)

Early clinical predictors of disease progression in relapsing-remitting multiple sclerosis: the Oxford UK cohort
von: Wakerley, B, et al.
Veröffentlicht: (2011)

ASIC1 Blockade in Primary Progressive Multiple Sclerosis: Evidence of Neuroprotection with Amiloride
von: Arun, T, et al.
Veröffentlicht: (2013)

AMILORIDE TREATMENT AMELIORATES MRI SURROGATE MARKERS OF NEURODEGENERATION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
von: Arun, T, et al.
Veröffentlicht: (2012)

Guidelines for differential diagnosis of suspected multiple sclerosis.
von: Palace, J
Veröffentlicht: (2009)

New treatments and azathioprine in multiple sclerosis.
von: Palace, J, et al.
Veröffentlicht: (1997)

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
von: Noseworthy, J
Veröffentlicht: (1991)

Modelling progressive multiple sclerosis for new treatment strategies
von: Roodselaar, J
Veröffentlicht: (2019)

Natural history of primary progressive multiple sclerosis.
von: Ebers, G
Veröffentlicht: (2004)

Natural history of primary progressive multiple sclerosis
von: Ebers, G
Veröffentlicht: (2004)

Thalamic neurodegeneration in multiple sclerosis.
von: Cifelli, A, et al.
Veröffentlicht: (2002)

Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride
von: Arun, T, et al.
Veröffentlicht: (2013)

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
von: Arun, T, et al.
Veröffentlicht: (2013)

Interleukin-17 expression in multiple sclerosis
von: Tzartos, J, et al.
Veröffentlicht: (2006)

Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
von: Parry, A, et al.
Veröffentlicht: (2003)

beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis
von: Parry, A, et al.
Veröffentlicht: (2002)

UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.
von: Palace, J, et al.
Veröffentlicht: (2014)

COMPARING MRI MEASURES OF MYELIN INTEGRITY AS SURROGATE MARKERS FOR THE CLINICAL EXPRESSION OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
von: Matthews, L, et al.
Veröffentlicht: (2010)

Primary progressive multiple sclerosis: Brain MRI findings
von: Kremenchutzky, M, et al.
Veröffentlicht: (1999)

Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
von: Palace, J
Veröffentlicht: (2009)

DIRECT COMPARISON OF MULTIPLE NONLESIONAL IMAGING MEASURES TO ASSESS THEIR POWER TO MEASURE TREATMENT EFFECTS OVER 1 YEAR IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
von: Arun, T, et al.
Veröffentlicht: (2010)

Treatment of active secondary progressive multiple sclerosis with treosulfan.
von: Wiendl, H, et al.
Veröffentlicht: (2007)

The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
von: Cottrell, D, et al.
Veröffentlicht: (1999)

Modafinil for multiple sclerosis fatigue: does it work?
von: Littleton, E, et al.
Veröffentlicht: (2010)